Search Results Search Sort by RelevanceMost Recent Medicine and Society Apr 2014 Consent and Rights in Comparative Effectiveness Trials Collin O’Neil, PhD Some commentators say comparative trials of FDA-approved drugs are overburdened by current Common Rule regulations and that researchers should not be required to obtain explicit consent for participation in the most innocuous of these trials. Virtual Mentor. 2014;16(4):289-294. doi: 10.1001/virtualmentor.2014.16.4.msoc1-1404. Medicine and Society Nov 2019 How to Integrate Lived Experience Into Quality-of-Life Assessment in Patients Considering Facial Transplantation Laura L. Kimberly, MSW, MBE, Allyson R. Alfonso, Elie P. Ramly, MD, Rami S. Kantar, MD, Arthur L. Caplan, PhD, and Eduardo D. Rodriguez, MD, DDS Facial transplantation must establish approaches to assessing QoL in candidates and recipients that use meaningful outcomes. AMA J Ethics. 2019;21(11):E980-987. doi: 10.1001/amajethics.2019.980.
Medicine and Society Apr 2014 Consent and Rights in Comparative Effectiveness Trials Collin O’Neil, PhD Some commentators say comparative trials of FDA-approved drugs are overburdened by current Common Rule regulations and that researchers should not be required to obtain explicit consent for participation in the most innocuous of these trials. Virtual Mentor. 2014;16(4):289-294. doi: 10.1001/virtualmentor.2014.16.4.msoc1-1404.
Medicine and Society Nov 2019 How to Integrate Lived Experience Into Quality-of-Life Assessment in Patients Considering Facial Transplantation Laura L. Kimberly, MSW, MBE, Allyson R. Alfonso, Elie P. Ramly, MD, Rami S. Kantar, MD, Arthur L. Caplan, PhD, and Eduardo D. Rodriguez, MD, DDS Facial transplantation must establish approaches to assessing QoL in candidates and recipients that use meaningful outcomes. AMA J Ethics. 2019;21(11):E980-987. doi: 10.1001/amajethics.2019.980.